4.3 Thyroid & Adrenal Disorders in Ambulatory Care
Key Takeaways
- Levothyroxine replacement in primary hypothyroidism is dosed at approximately 1.6 mcg/kg/day using Ideal Body Weight (IBW) in healthy adults, but must be reduced to 25 to 50 mcg/day in older adults or patients with known coronary artery disease to prevent myocardial ischemia and tachyarrhythmias.
- Oral levothyroxine bioavailability is heavily diminished by multivalent cations (calcium, iron), bile acid sequestrants, sucralfate, and PPIs; it must be ingested with a full glass of water 30–60 minutes before breakfast or at bedtime ≥3–4 hours after the final meal.
- During pregnancy, maternal thyroid hormone demands surge by 25% to 30% upon conception; pre-existing hypothyroidism requires immediate empirical dose escalation (e.g., taking two extra doses weekly) and frequent TSH monitoring targeting <2.5 mIU/L.
- Methimazole is the preferred antithyroid drug for Graves disease due to once-daily dosing and lower hepatotoxicity risk, but Propylthiouracil (PTU) is the mandatory drug of choice in the first trimester of pregnancy and thyroid storm (inhibits peripheral T4 to T3 conversion).
- Primary adrenal insufficiency requires glucocorticoid replacement (hydrocortisone 15–25 mg daily divided BID/TID) plus mineralocorticoid replacement (fludrocortisone 0.05–0.2 mg daily); acute illness mandates doubling or tripling daily oral steroid doses ("stress dosing") and carrying emergency parenteral hydrocortisone.
4.3 Thyroid & Adrenal Disorders in Ambulatory Care
BCACP Exam Anchor: Endocrine pharmacotherapy beyond diabetes focuses heavily on thyroid and adrenal axis management. Core exam competencies include calculating weight-based levothyroxine regimens, recognizing malabsorption drug-drug interactions, adjusting replacement therapy in pregnancy and geriatric coronary disease, managing thionamide toxicities (agranulocytosis vs hepatotoxicity), executing pregnancy trimester switches (PTU vs Methimazole), and implementing life-saving stress-dose glucocorticoid protocols in adrenal insufficiency.
1. Primary Hypothyroidism: Dosing & Administration Protocols
Primary hypothyroidism is characterized by an elevated serum Thyroid-Stimulating Hormone (TSH) and low free thyroxine (Free T4), most commonly caused by autoimmune Hashimoto's thyroiditis, radioactive iodine ablation, or thyroidectomy.
Levothyroxine Dosing Strategies
- Healthy Non-Elderly Adults (<50 years without CAD):
- Full Replacement Dose: $\mathbf{1.6\text{ mcg/kg/day}}$ calculated based on Ideal Body Weight (IBW) (or adjusted body weight in severe obesity).
- Older Adults (Age >50–60 years) or Patients with Coronary Artery Disease (CAD):
- Initial Conservative Dose: 25 to 50 mcg once daily.
- Clinical Rationale: Rapid restoration of thyroid hormone increases myocardial oxygen consumption, heart rate, and contractility, which can precipitate angina, myocardial infarction, or atrial fibrillation in ischemic heart disease.
- Titration: Increase by 12.5 to 25 mcg every 4 to 8 weeks based on clinical symptoms and TSH.
- Subclinical Hypothyroidism (Elevated TSH with Normal Free T4):
- Treat if $\text{TSH} > 10\text{ mIU/L}$, or if $\text{TSH } 5\text{ to } 10\text{ mIU/L}$ with symptomatic presentation, positive anti-TPO antibodies, goiter, or pregnancy/fertility planning. Start low (25–50 mcg/day).
| Patient Population | Initial Levothyroxine Dosing | Monitoring Interval | Target TSH Range |
|---|---|---|---|
| Young / Healthy Non-Elderly | 1.6 mcg/kg/day IBW (~100–125 mcg QD) | TSH every 4–8 weeks until stable | 0.5–4.5 mIU/L |
| Older Adults (≥60 years) / Known CAD | 25–50 mcg QD (start 12.5–25 mcg if severe CAD) | TSH every 6–8 weeks; titrate by 12.5–25 mcg | 0.5–4.5 mIU/L (or 1.0–5.0 mIU/L in elderly) |
| Pregnancy with Pre-Existing Hypothyroidism | Increase pre-pregnancy dose by 25% to 30% (take 2 extra tabs/week) | TSH every 4 weeks through 1st half of pregnancy | < 2.5 mIU/L (1st trimester); < 3.0 mIU/L (2nd/3rd) |
| Subclinical Hypothyroidism (TSH >10) | 25–50 mcg QD | TSH every 6–8 weeks | 0.5–4.5 mIU/L |
2. Levothyroxine Bioavailability, Interactions & Pregnancy
Administration Rules & Absorption Nuances
- Fasting Morning Administration: Take with a full glass (6–8 oz) of plain water at least 30 to 60 minutes before breakfast on an empty stomach.
- Bedtime Administration Alternative: Take at bedtime at least 3 to 4 hours after the evening meal. (Shown in clinical trials to achieve equivalent or slightly superior TSH suppression compared to morning dosing due to slower gastrointestinal transit).
Significant Drug Interactions Impairing Levothyroxine Absorption
Levothyroxine Absorption Impairment
│
┌───────────────────────────────────────────┼───────────────────────────────────────────┐
▼ ▼ ▼
Multivalent Cations & Binders Gastric Acid Suppressors Hepatic CYP Inducers
(Separate by at least 4 hours) (Impair Dissolution/Ionization) (Accelerate T4 Elimination)
• Calcium carbonate / citrate • Proton Pump Inhibitors (Omeprazole) • Rifampin
• Ferrous sulfate (Iron) • H2 Receptor Antagonists (Famotidine) • Phenytoin, Carbamazepine
• Aluminum/Magnesium antacids • Atrophic Gastritis / H. pylori • Phenobarbital
• Bile acid sequestrants (Cholestyramine) *Action: May require higher T4 dose* *Action: Monitor TSH; increase T4*
• Sucralfate, Sevelamer, Sodium Polystyrene
Hypothyroidism in Pregnancy
- Physiology: Estrogen surges stimulate hepatic thyroid-binding globulin (TBG) synthesis, while human chorionic gonadotropin (hCG) weakly stimulates TSH receptors and placental deiodinases degrade T4. Fetal neurocognitive development depends entirely on maternal T4 transfer during the first trimester.
- Clinical Protocol: Upon confirmation of pregnancy, women taking levothyroxine should immediately increase their weekly dose by 25% to 30% (standard practical instruction: take 2 additional daily doses per week, e.g., take 2 tablets on Mondays and Thursdays, and 1 tablet on other days).
- Monitoring: Order serum TSH every 4 weeks through gestational week 20, and at least once near week 30. Maintain $\text{TSH} < 2.5\text{ mIU/L}$.
3. Hyperthyroidism & Thionamide Pharmacotherapy
Hyperthyroidism is characterized by suppressed TSH ($<0.01\text{ mIU/L}$) and elevated Free T4 / Free T3, most commonly resulting from Graves' disease (thyrotropin receptor autoantibodies [TRAb]), toxic multinodular goiter, or toxic adenoma.
Comparative Pharmacology of Antithyroid Drugs (Thionamides)
| Property / Parameter | Methimazole (MMI) (Tapazole) | Propylthiouracil (PTU) |
|---|---|---|
| Mechanism of Action | Inhibits thyroid peroxidase (TPO); blocks iodine organification and coupling | Inhibits TPO AND inhibits peripheral conversion of $\text{T}_4$ to $\text{T}_3$ (5'-deiodinase inhibition) |
| Dosing & Half-Life | 10–30 mg PO once daily (long intrathyroidal half-life) | 100–150 mg PO TID (every 8 hours) |
| Preferred Clinical Role | First-line agent for non-pregnant adults, children, and 2nd/3rd trimesters of pregnancy | 1st trimester of pregnancy, Thyroid Storm, and patient with MMI intolerance |
| Boxed Warning / Severe Toxicity | Lower hepatotoxicity risk; teratogenic in 1st trimester (aplasia cutis, choanal atresia) | Boxed Warning: Severe, fulminant Hepatotoxicity / Acute Liver Failure |
| Shared Severe Toxicity | Agranulocytosis (ANC <500/mm³; incidence ~0.2–0.5%). Sudden onset. Vasculitis. | Agranulocytosis (ANC <500/mm³; cross-reactivity ~50%). ANCA-positive vasculitis. |
Pregnancy Management in Hyperthyroidism
- 1st Trimester: Use Propylthiouracil (PTU) to avoid methimazole-associated embryopathies (aplasia cutis, esophageal atresia).
- 2nd & 3rd Trimesters: Switch from PTU to Methimazole at the start of the second trimester (week 13–16) to avoid maternal fulminant hepatotoxicity.
- Dosing Goal: Maintain maternal Free T4 at the upper limit of normal using the lowest effective thionamide dose to prevent fetal goiter and hypothyroidism.
Symptomatic & Adjunctive Pharmacotherapy
- Beta-Blockers: Non-selective beta-blocker propranolol (20–40 mg PO QID) or cardioselective atenolol (25–50 mg QD) is initiated immediately to control adrenergic manifestations (palpitations, resting tachycardia, tremor, heat intolerance, anxiety). High-dose propranolol ($>160\text{ mg/day}$) also mildly inhibits peripheral T4 to T3 conversion.
- Agranulocytosis Patient Counseling: Instruct patients to immediately stop thionamide therapy and report to a clinic or emergency department for a Stat CBC with differential if they develop a sudden fever, sore throat, or signs of infection.
4. Adrenal Insufficiency & Glucocorticoid Replacement
Adrenal insufficiency (AI) is divided into Primary AI (Addison's Disease) (destruction of the adrenal cortex causing loss of glucocorticoids, mineralocorticoids, and androgens) and Secondary/Tertiary AI (hypothalamic-pituitary impairment or chronic exogenous steroid suppression, preserving mineralocorticoids via the renin-angiotensin-aldosterone system).
Replacement Regimens
- Glucocorticoid Replacement (Primary & Secondary AI):
- Hydrocortisone (Cortisol): 15 to 25 mg daily administered in divided doses to mimic physiologic circadian cortisol secretion:
- Twice-Daily Regimen: 10 to 15 mg upon waking, and 5 to 10 mg in early/mid-afternoon (~2:00 PM to 4:00 PM).
- Alternative: Prednisone 3 to 5 mg once daily in the morning (longer duration, but lacks exact physiologic rhythm).
- Hydrocortisone (Cortisol): 15 to 25 mg daily administered in divided doses to mimic physiologic circadian cortisol secretion:
- Mineralocorticoid Replacement (Primary AI Only):
- Fludrocortisone: 0.05 to 0.2 mg once daily in the morning.
- Dose Titration: Monitor blood pressure, orthostatics, serum sodium, potassium, and plasma renin activity (PRA). Secondary AI does not require fludrocortisone.
Stress Dosing & Adrenal Crisis Prevention ("Sick-Day Rules")
Patients with adrenal insufficiency are unable to mount a physiologic stress response, predisposing them to fatal hypotension, shock, and vascular collapse during physiological stress.
Adrenal Insufficiency Stress Protocol
│
┌───────────────────────────────────────────────┼───────────────────────────────────────────────┐
▼ ▼ ▼
Mild Illness / Fever Moderate Stress / Minor Surgery Severe Stress / Major Surgery /
(Fever >38°C, URI, Gastroenteritis) (Dental surgery, moderate trauma) Major Trauma / Emesis / Inability to Swallow
│ │ │
▼ ▼ ▼
Double or Triple Daily Oral Take 50 mg Hydrocortisone PO Administer Emergency Injectable
Hydrocortisone for 2 to 3 days prior to procedure, then 25-50 mg Hydrocortisone 100 mg IM/IV immediately;
(e.g., 20 mg AM / 10 mg PM) daily until recovered Call 911 / Transport to Emergency Dept
- Emergency Hydrocortisone Injection Kit: Every patient must carry an emergency injection kit (Solu-Cortef 100 mg Act-O-Vial with syringe/needle for IM injection) and wear medical alert identification. If vomiting or diarrhea prevents oral retention, the patient/family must inject 100 mg IM and seek emergency care immediately.
A 26-year-old female with well-controlled primary hypothyroidism on levothyroxine 88 mcg once daily presents to the ambulatory clinic after a positive home pregnancy test (confirmed at 5 weeks gestation). Her baseline pre-pregnancy TSH was 1.8 mIU/L. Which of the following is the most appropriate management plan for her levothyroxine therapy?
A 31-year-old female at 8 weeks gestation is diagnosed with symptomatic Graves' hyperthyroidism. Her labs reveal TSH <0.01 mIU/L and Free T4 3.4 ng/dL (elevated). She has resting tachycardia (HR 112 bpm) and severe tremor. Which of the following pharmacotherapeutic regimens represents the most appropriate initial management?
A 44-year-old male with primary adrenal insufficiency (Addison's disease) is maintained on hydrocortisone 15 mg in the morning and 5 mg at 3:00 PM, along with fludrocortisone 0.1 mg once daily. He calls the clinical pharmacist reporting acute onset of fever (101.8°F / 38.8°C), body aches, and productive cough. He is fully conscious and able to tolerate oral fluids and medications. What advice should the pharmacist provide regarding his corticosteroid regimen?